Bloomberg on MSN3mon
Bristol Raises Guidance on Demand for Eliquis, New DrugsTwo of its biggest sellers — Eliquis and cancer immunotherapy Opdivo — will lose patent exclusivity in the coming years.
The top 10 patented drugs getting expired in the coming years in the US, include Pembrolizumab, sold under the brand name Keytruda by Merck and Co., Eliquis ... for Indian generic drug manufacturers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback